UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
December 27, 2018
____________________________
ChineseInvestors.com, Inc.
(Exact name of registrant as specified in its charter)
____________________________
Indiana | 000-54207 | 35-2089868 |
(State of Organization) | (Commission File Number) | (I.R.S. Employer Identification Number) |
227 W. Valley Blvd. #208A, San Gabriel, CA | 91776 |
(Address of principal executive offices) | (Zip Code) |
(626) 589-2468
(Registrant’s telephone number, including area code)
Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfying the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01 Other Events.
The Company issued a press release in which it announces that it has engaged Boustead Securities for the planned initial public offering of its wholly-owned subsidiary, CBD Biotechnology Co., Ltd.
Exhibit 99.1 Press release announcing CIIX’s engagement of Boustead Securities for the planned initial public offering of its wholly-owned subsidiary, CBD Biotechnology Co., Ltd.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit 99.1 | Press release |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: December 27, 2018
ChineseInvestors.com, Inc.
By: /s/ Wei Wang
Name: Wei Wang
Title: Chief Executive Officer
2 |
Exhibit 99.1
ChineseInvestors.com, Inc. Engages Boustead Securities, LLC
For Planned IPO of its Wholly-Owned Subsidiary, CBD Biotech
SAN GABRIEL, California, and SHANGHAI, China—December 27, 2018 /PRNewswire/ -- ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), a financial information website for Chinese-speaking investors, today announced that it has retained Boustead Securities, LLC as underwriter for the planned Initial Public Offering (“IPO”) of its wholly-owned foreign enterprise, CBD Biotech Co. Ltd. (“CBD Biotech”), concurrently with a listing on a national securities exchange.
Mr. Warren Wang, Founder, CEO and Chairman of ChineseInvestors.com, commented “This is part of a series of actions we have put into place to execute on our strategic plan to spin-out CBD Biotech. Additionally, we believe that listing on a national exchange speaks to the quality of CBD Biotech, will provide us with market visibility and access to capital, and further support our growth strategy. We look forward to working with Boustead Securities as IPO sponsor and underwriter.”
Boustead Securities' Dan McClory, Managing Director, Head of China, and Head of Equity Capital Markets, stated, "We believe CBD Biotech can potentially gain a first mover advantage in the Chinese CBD market, and could be well received in the public markets. Boustead looks forward to supporting CBD Biotech’s growth mission with capital through the planned IPO and national exchange listing."
About ChineseInvestors.com (OTCQB: CIIX)
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) through its wholly-owned subsidiary CBD Biotech, retail, online and direct sales of hemp-based products and other health-related products.
For more information, visit ChineseInvestors.com
Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom
Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh
Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom;
https://www.facebook.com/Chineseinvestors.com.english
Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn
1 |
About Boustead Securities, LLC
Boustead Securities, LLC ("Boustead") is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead's core value proposition is the ability to create opportunity through innovative solutions and tenacious execution. With experienced professionals in the United States and around the world, Boustead's team moves quickly and provides a broad spectrum of sophisticated financial advice and services. For more information, visit www.boustead1828.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.
Contact:
ChineseInvestors.com, Inc.
227 W. Valley Blvd., #208 A
San Gabriel, CA 91776
Investor Relations:
Alan Klitenic
+1-214-636-2548
Corporate Communications:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
+212-418-1217 Office
Editor@NetworkNewsWire.com
SOURCE ChineseInvestors.com, Inc.
2 |